學術研究成果/Publication
基本資料/Profiles
姓名/Name: 吳伯元 性別/Gender:
英文姓名/
English Name:
Po-Yuan Wu 英文縮寫/
Abbreviation:
任職單位/
Affiliation:
1.醫學院醫學系學士班皮膚學科(助理教授) / Department of Dermatology (Assistant Professor)
2.中國附醫皮膚科(代理主任) / Division of Dermatology (Acting Director)
Email: poyuan@mail.cmu.edu.tw
研究專長/Fields of Specialty
1﹒ 皮膚科學 醫學資訊 流行病學
 
期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
SCI論文 沈宛倢(Wan-Chieh Shen)、吳伯元(Po-Yuan Wu)*,Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report,JOURNAL OF CUTANEOUS PATHOLOGY,2018 Sep,():
SCI論文 (Ya-Han Huang)、吳伯元(Po-Yuan Wu)、溫國慶(Wen, Kuo-Ching)、林俊義(Chien-Yih Lin)、江秀梅(Chiang, Hsiu-Mei)*,Protective effects and mechanisms of Terminalia catappa L. methenolic extract on hydrogen-peroxide-induced oxidative stress in human skin fibroblasts,BMC Complementary and Alternative Medicine,2018 Jul,():
SCI論文 沈宛倢(Wan-Chieh Shen)、吳伯元(Wu, Po-Yuan)*,Intralesional corticosteroid induced perilesional and perilymphatic linear hypopigmentation successfully treated by 308-nm excimer light,DERMATOLOGIC SURGERY,2018 May,():
SCI論文 吳伯元(Wu, Po-Yuan)、(Ya-Jhen You)、劉伊容(Liu, Yi-Jung)、(Chien-Wei Hou)、吳錦生(Wu, Chin-Sheng (Wu, Jiin-Sheng))、溫國慶(Wen, Kuo-Ching)、(Chien-Yih Lin)、江秀梅(Chiang, Hsiu-Mei)*,Sesamol Inhibited Melanogenesis by Regulating Melanin-Related Signal Transduction in B16F10 Cells,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2018 Apr,19(4):
SCI論文 吳伯元(Wu, Po-Yuan)、呂佳陵(LYU,JIA-LING)、劉伊容(Liu, Yi-Jung)、簡筳宜(Ting-Yi Chien)、許皓宸(Hao-Cheng Hsu)、溫國慶(Wen, Kuo-Ching)、江秀梅(Chiang, Hsiu-Mei)*,Fisetin Regulates Nrf2 Expression and the Inflammation-Related Signaling Pathway to Prevent UVB-Induced Skin Damage in Hairless Mice,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2017 Oct,18():2188
SCI論文 郭悅雄(Kuo, Yueh-Hsiung)、吳伯元(Wu, Po-Yuan)、Chien-Wen C(Chien-Wen Chen)、Ping Lin(Ping Lin)、溫國慶(Wen, Kuo-Ching)、林俊義(Chien-Yih Lin)、江秀梅(Chiang, Hsiu-Mei)*,N-(4-bromophenethyl) Caffeamide Protects Skin from UVB-Induced Inflammation Through MAPK/IL-6/NF-κB-Dependent Signaling in Human Skin Fibroblasts and Hairless Mouse Skin,MOLECULES,2017 Sep,():
SCI論文 周仁偉(Jen-Wei Chou)、林映藍(Yin-Lan Lin)、鄭庚申(Cheng, Ken-Sheng)、吳伯元(Wu, Po-Yuan)、朱珈妤(Ju, Teressa Reanne)*,Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.,INTERNAL MEDICINE,2017 Jul,56(14):1831-1837
SCI論文 吳伯元(Wu, Po-Yuan)、(Chi-Chang Huang)、(Yin Chu)、(Ya-Han Huang)、(Ping Lin)、(Yu-Han Liu)、溫國慶(Kuo-Ching Wen)、林俊義(Chien-Yih Lin)、(Mei-Chich Hsu)、江秀梅(Hsiu-Mei Chiang)*,Alleviation of Ultraviolet B-Induced Photodamage by Coffea arabica Extract in Human Skin Fibroblasts and Hairless Mouse Skin,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2017 Apr,18(782):1-19
SCI論文 郭悅雄(Yueh-Hsiung Kuo)、(Chien-Chia Chen)、吳伯元(Wu, Po-Yuan)、吳錦生(Wu, Chin-Sheng (Wu, Jiin-Sheng))、(Ping-Jyun Sung)、林俊義(Chien-Yih Lin)*、江秀梅(Hsiu-Mei Chiang)*,N-(4-Methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms,BMC Complementary and Alternative Medicine,2017 Jan,17(1):
SCI論文 蔡高頌(Kau-Sung Tsai)、(Chia-Sung Yen)、吳伯元、(Jen-Huai Chiang)、(Jui-Lung Shen)、楊中賢(Chung-Hsion Yang)、陳慧毅(Huey-Yi Chen)、陳永祥(Yung-Hsiang Chen)*、陳汶吉(Chen, Wen-Chi)*,Traditional Chinese Medicine Decreases the Stroke Risk of Systemic Corticosteroid Treatment in Dermatitis: A Nationwide Population-based Study,Evidence-based Complementary and Alternative Medicine,2015 Oct,2015(2015):543517-543517
SCI論文 江秀梅(Hsiu-Mei Chiang)、陳信君(HSIN-CHUN CHEN)、吳錦生(Wu, Chin-Sheng (Wu, Jiin-Sheng))、吳伯元、溫國慶(Kuo-Ching Wen)*,Rhodiola plants: Chemistry and biological activity,JOURNAL OF FOOD AND DRUG ANALYSIS,2015 Sep,23(3):359-369
SCI論文 吳伯元、林橙莉、宋鴻樟(Fung-Chang Sung)、周子傑(Tzu-Chieh Chou)*、李源德(Yuan-Teh, Lee),Increased risk of cardiovascular events in patients with Herpes Zoster: A population-based study,JOURNAL OF MEDICAL VIROLOGY,2014 Mar,86(5):772-777
SCI論文 方心禹(Hsin-Yu Fang)、吳伯元*、謝旭榮(Hsu-Jung Hsieh),Generalized Lichenoid Reaction to Black Tattoos with Spontaneous Resolution after skin biopsy,Dermatologica Sinica,2013 Dec,.(.):.-.
SCI論文 吳伯元、吳宏達(Hong-Dar Isaac Wu)、周子傑(Tzu-Chieh Chou)、宋鴻樟(Fung-Chang Sung)*,Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella,PLoS One,2013 Oct,8(10):e77709-e77709
SCI論文 李文豪(Wen-Hao Li)、涂智彥(Chih-Yen Tu)、謝德鈞(Te-Chun Hsieh)、吳伯元*,Zosteriform Skin Metastasis of Lung Cancer,CHEST,2012 Dec,142(6):1652-1654
SCI論文 林子鈞(Tzu-Chun Lin)、吳伯元*,Painful annular pustular drug eruption induced by erlotinib in a case of non-small-cell lung cancer,CUTIS,2011 Dec,88(6):281-283
SCI論文 李文豪(Wen-Hao Li)、戴偉竣(Wei-Chun Tai)、吳伯元*,Congenital erythropoietic porphyria,Dermatologica Sinica,2011 Dec,():
SCI論文 林子鈞(Tzu-Chun Lin)、李聰亮(Tsong-Liang Lee)、林智一(Tze-Yi Lin)、吳伯元*,An infrequent case of neoplasm with fibroepithelioma of Pinkus and hidradenomatous features,AMERICAN JOURNAL OF DERMATOPATHOLOGY,2011 Oct,33(7):750-752
SCI論文 林子鈞(Tzu-Chun Lin)、吳伯元、林智一(Tze-Yi Lin)、葉士芃(Su-Peng Yeh)、陳世昌(Shyh-chang Chen)、李聰亮(Tsong-Liang Lee)*,Langerhans cell hyperplasia in the tumor stage of mycosis fungoides: a mimic of Langerhans cell histiocytosis,Dermatologica Sinica,2011 Sep,29(3):101-105
SCI論文 林子鈞(Tzu-Chun Lin)、吳伯元、林智一(Tze-Yi Lin)、李聰亮*,An infrequent plexiform variant of schwannoma of the glans penis: a rare finding,ASIAN JOURNAL OF ANDROLOGY,2010 Feb,():
Other論文 毛明雅(ming-ya mao)、吳孟澤(Meng-Tse Wu)、謝旭榮(Hsu-Jung Hsieh)、林智一(Tze-Yi Lin)、吳伯元*,a solitary halo neurofibroma- a case report,Dermatologica Sinica,2009 Sep,27(3):181-185
 
研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
1﹒ Coexistence of cutaneous Langerhans cell histiocytosis and Reticulohistiocytosis with initial presentation of skull lesions,2018 American Academy of Dermatology Annual Meeting,San Diego, California,2018.2.16 ~ 2018.2.20,
2﹒ 以308準分子光成功治療病灶內類固醇注射所導致之色素脫失,臺灣皮膚科醫學會第43屆年會,台北國際會議中心,2017.11.17 ~ 2017.11.19,
3﹒ A case of Netherton Syndrome with bamboo hair at birth,臺灣皮膚科醫學會第42屆年會暨第8屆亞洲色素細胞會議,高雄,2016.11.12 ~ 2016.11.13,
4﹒ Population Study on Risk of Pulmonary Tuberculosis Related to Herpes Zoster and Comorbidity,The 23RD World Congress of Dermatology,加拿大溫哥華,2015.6.8 ~ 2015.6.13,
5﹒ Antipruritic Effects of Lower Temperature Stimulation at Acupoints in the Mice Model,9th Asian Dermatological Congress 2013,Hong Kong,2013.7.10 ~ 2013.7.13,
6﹒ Patients with chronic renal failure and risk of developing erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis disease spectrum,台灣皮膚科醫學會第36屆年會暨學術研討會,台大醫院國際會議中心,2010.11.20 ~ 2010.11.21,
7﹒ 台灣脂漏性皮膚炎之流行病學研究,台灣皮膚科醫學會年會,高雄市高雄醫學大學,2009.11.21 ~ 2009.11.22,
8﹒ ,台灣皮膚科醫學會年會,高雄市,2009.11.21 ~ 2009.11.22,
9﹒ Risk factors for chickenpox incidence in Taiwan from a ;arge-scale computerized database,臺灣皮膚科醫學會第34屆年會暨學術研討會,長庚大學,2008.11.15 ~ 2008.11.16,
 
研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
1﹒ 個別型,MOST 107-2314-B-039-037-,魏長菁(Chang-Ching Wei),顏宏融(Hung-Rong Yen)、吳伯元(Po-Yuan Wu),科技部,探討濕敷療法在中度異位性皮膚炎的兒童皮膚屏障功能的重建、皮膚微生物群落生物多樣性、疾病的嚴重度和生活品質的影響,$950000,2018.8.1 ~ 2019.7.31
2﹒ 個別型,MOST 107-2314-B-039-069-,洪慧珊(Huei-Shan Hung),陳怡文(Yi-Wen Chen)、吳伯元(Po-Yuan Wu),科技部,新穎普魯蘭-膠原蛋白-奈米金/生物水膠結合三維細胞片製備皮膚傷口敷料:以體外細胞及體內動物實驗探討基材於皮膚奈米組織工程之應用,$760000,2018.8.1 ~ 2019.7.31
3﹒ 個別型,CMU107-BC-7,江秀梅,吳伯元(Po-Yuan Wu),本校(含附醫),蜂膠成分用於預防長波紫外光引起光損傷及皮膚照護作用與機轉研究,$350000,2018.8.1 ~ 2019.7.31
4﹒ 產學合作,106426CA,江秀梅(Chiang, Hsiu-Mei),溫國慶(Wen, Kuo-Ching)、吳伯元(Po-Yuan Wu),大江生醫股份有限公司,天山雪蓮萃取物抗老臨床試驗,$400000,2018.2.1 ~ 2019.8.31
5﹒ 個別型,DMR-107-038,吳伯元(Wu, Po-Yuan),江秀梅(Chiang, Hsiu-Mei),附醫院內計畫,植萃物及植化素之化妝保健品於預防光損傷及皮膚照護作用評估與機轉研究,$200000,2017.8.1 ~ 2018.7.31
6﹒ 產學合作,105426CQ,江秀梅(Chiang, Hsiu-Mei),溫國慶(Wen, Kuo-Ching)、吳伯元(Wu, Po-Yuan),台灣檢驗科技股份有限公司,蘭花胚精華,$73500,2017.3.25 ~ 2017.8.31
7﹒ 國家型,M0HW106-CMAP-M-114-112105,顏宏融(Hung-Rong Yen),魏長菁(Chang-Ching Wei)、鄭慧滿(Hui-Man Cheng)、吳伯元(Wu, Po-Yuan)、賴琬郁(Wan-Yu Lai)、楊佩珊(Pei-Shan Yang),衛福部,106年度「促進中醫多元發展計畫」,分項1:建構中西醫合作照護模式計畫,$920000,2017.1.17 ~ 2017.12.15
8﹒ 臨床試驗與研究計畫,CMUH106-REC2-112,吳伯元(Wu, Po-Yuan),張廖年峰(Nien-Feng Chang Liao),附醫廠商計畫,一項雙盲、隨機分配、安慰劑對照、藥物增量之第一期臨床試驗,評估兩種不同濃度、每日使用二次的KX01軟膏於斑塊型乾癬患者之安全性、耐受性及活性(療效),$339251,2017.1.1 ~ 2017.12.31
9﹒ 臨床試驗與研究計畫,CMUH106-REC3-093,黃春明(Huang, Chung-Ming),吳伯元(Wu, Po-Yuan)、黃柏豪(Bo-Hau Huang)、洪偉哲(Wei-Jhe Hong),附醫廠商計畫,針對曾對至少一種非生物性疾病修飾型抗風濕藥物(DMARD)反應不佳的活動性乾癬性關節炎受試者中,對ABT-494與安慰劑以及Adalimumab進行比較的一項第三期、隨機分配、雙盲試驗–SELECT–PsA 1,$11222080,2017.1.1 ~ 2017.12.31
10﹒ 臨床試驗與研究計畫,CMUH104-REC2-102,林振源(Chen-Yuan Lin),連銘渝(Ming-Yu Lein)、許致榮(Chih-Jung Hsu)、吳伯元(Wu, Po-Yuan)、李宗勳(Li, Tzong-Shiun),附醫廠商計畫,完全切除第IIIb/c或第IV期黑色素瘤且具高復發風險受試者接受Nivolumab相較於Ipilimumab作為術後免疫治療的一項第3期、隨機分配、雙盲試驗,$4344152,2017.1.1 ~ 2017.12.31
11﹒ 產學合作,10542661,溫國慶(Kuo-Ching Wen),江秀梅(Hsiu-Mei Chiang)、吳伯元(Wu, Po-Yuan),財團法人醫藥工業技術發展中心,委託檢測,$52500,2016.9.22 ~ 2017.4.30
12﹒ 個別型,CMU105-ASIA-08,江秀梅(Hsiu-Mei Chiang),吳伯元(Wu, Po-Yuan)、林俊義,本校(含附醫),菇類及天然物與產品於黑色素調控及光老化作用與機制之研究開發,$500000,2016.8.1 ~ 2017.7.31
13﹒ 產學合作,104426CR,江秀梅(Hsiu-Mei Chiang),溫國慶(Kuo-Ching Wen)、吳伯元(Wu, Po-Yuan),財團法人工業技術研究院,洋桔梗萃取之人體試驗評估,$330000,2016.4.18 ~ 2017.5.31
14﹒ 個別型,104426DF,江秀梅(Hsiu-Mei Chiang),溫國慶(Kuo-Ching Wen)、吳伯元(Wu, Po-Yuan),台灣源本初見貿易有限公司,源本初見水嫩產品皮膚保溼度研究,$228696,2016.4.18 ~ 2017.4.30
15﹒ 個別型,104426DH,江秀梅(Hsiu-Mei Chiang),吳伯元(Wu, Po-Yuan)、溫國慶(Kuo-Ching Wen),台灣源本初見貿易有限公司,源本初見青春系列產品減緩痘疤及色素沉澱功效評估研究,$276522,2016.4.1 ~ 2017.1.31
16﹒ 臨床試驗與研究計畫,DMR100-IRB-174,吳伯元(Wu, Po-Yuan),附醫廠商計畫,生殖器濕疣之疾病影響研究,$7560,2016.1.1 ~ 2016.12.31
17﹒ 臨床試驗與研究計畫,CMUH104-REC2-102,林振源(Chen-Yuan Lin),連銘渝(Ming-Yu Lein)、許致榮(Chih-Jung Hsu)、吳伯元(Wu, Po-Yuan)、李宗勳(Tzong-Shiun Li),附醫廠商計畫,完全切除第IIIb/c或第IV期黑色素瘤且具高復發風險受試者接受Nivolumab相較於Ipilimumab作為術後免疫治療的一項第3期、隨機分配、雙盲試驗,$1279400,2016.1.1 ~ 2016.12.31
18﹒ 產學合作,103426AH,江秀梅(Hsiu-Mei Chiang),吳伯元,良冠生技有限公司,百匡-肌因極潤系列有效性試驗評估,$260000,2015.2.1 ~ 2015.9.30
19﹒ 個別型,CMU99-TC-38,吳伯元,周子傑(Tzu-Chieh Chou)、楊雅斐(Ya-Fei Yang),本校(含附醫),尿毒性搔癢症及皮膚病變之流行病學研究,$150000,2011.4.1 ~ 2012.3.31
20﹒ 產學合作,096426G4,溫國慶(Kuo-Ching Wen),江秀梅、吳伯元,海昌生物科技股份有限公司,PEPTIOMAX?效能評估,$750000,2008.4.1 ~ 2008.11.30
21﹒ 個別型,DMR-97-145,吳伯元,吳孟澤(Meng-Tse Wu),附醫院內計畫,Imiquimod誘發皮膚癌細胞凋亡作用機轉之研究,$200000,2008.2.1 ~ 2008.12.31